Quick Answer ABEONA THERAPEUTICS INC. reported Operating Income of -$89.45 million for fiscal year 2025. ABEONA THERAPEUTICS INC. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$89.45M -39.3% 2024 -$64.21M -36.2% 2023 -$47.13M +7.4% 2022 -$50.91M +43.3% 2021 -$89.84M -10.3% 2020 -$81.42M -5.6% 2019 -$77.09M -32.5% 2018 -$58.17M -109.0% 2017 -$27.84M … Read more
Quick Answer ABEONA THERAPEUTICS INC. reported R&D Expense of $26.81 million for fiscal year 2025. ABEONA THERAPEUTICS INC. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $26.81M -22.0% 2024 $34.36M +10.5% 2023 $31.09M +7.3% 2022 $28.96M -25.2% 2021 $38.73M +28.5% 2020 $30.14M -37.9% 2019 $48.57M +25.5% 2018 $38.70M +127.8% 2017 $16.99M … Read more
Quick Answer ABEONA THERAPEUTICS INC. reported Long-Term Debt of $7.81 million for fiscal year 2025. ABEONA THERAPEUTICS INC. Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $7.81M -40.1% 2024 $13.04M — Quarterly Long-Term Debt Quarter Ending Long-Term Debt YoY QoQ September 30, 2025 $10.86M -23.5% -22.4% June 30, 2025 $14.01M -13.2% … Read more
Quick Answer ABEONA THERAPEUTICS INC. reported Stockholders Equity of $159.22 million for fiscal year 2025. ABEONA THERAPEUTICS INC. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $159.22M +261.6% 2024 $44.03M +197.0% 2023 $14.83M -44.6% 2022 $26.76M -36.8% 2021 $42.37M -58.7% 2020 $102.55M -42.5% 2019 $178.43M +33.1% 2018 $134.04M -21.2% 2017 $170.10M … Read more
Quick Answer ABEONA THERAPEUTICS INC. reported Cash and Equivalents of $78.44 million for fiscal year 2025. ABEONA THERAPEUTICS INC. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $78.44M +235.8% 2024 $23.36M +61.4% 2023 $14.47M +1.8% 2022 $14.22M -56.8% 2021 $32.94M +161.5% 2020 $12.60M -90.3% 2019 $129.26M +589.4% 2018 $18.75M … Read more
Quick Answer ABEONA THERAPEUTICS INC. reported Total Assets of $219.57 million for fiscal year 2025. ABEONA THERAPEUTICS INC. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $219.57M +101.6% 2024 $108.93M +70.2% 2023 $64.00M -0.3% 2022 $64.21M -19.3% 2021 $79.59M -47.4% 2020 $151.20M -32.3% 2019 $223.38M +28.1% 2018 $174.40M -2.4% 2017 $178.77M … Read more
Quick Answer ABEONA THERAPEUTICS INC. reported Diluted EPS of $1.01 per share for fiscal year 2025. ABEONA THERAPEUTICS INC. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $1.01 +165.2% 2024 -$1.55 +38.7% 2023 -$2.53 +54.2% 2022 -$5.53 +63.8% 2014 -$15.26 -602.0% 2013 $3.04 +684.6% 2012 -$0.52 — Quarterly Diluted EPS Quarter … Read more
Quick Answer ABEONA THERAPEUTICS INC. reported Net Income of $71.18 million for fiscal year 2025. ABEONA THERAPEUTICS INC. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 $71.18M +211.7% 2024 -$63.73M -17.6% 2023 -$54.19M -36.5% 2022 -$39.70M +53.3% 2021 -$84.94M -0.8% 2020 -$84.23M -10.4% 2019 -$76.28M -34.6% 2018 -$56.67M -107.4% 2017 -$27.32M … Read more
Quick Answer ABEONA THERAPEUTICS INC. reported Revenue (ASC 606) of $5.82 million for fiscal year 2025. ABEONA THERAPEUTICS INC. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $5.82M +66.3% 2023 $3.50M +147.5% 2022 $1.41M -52.9% 2021 $3.00M -70.0% 2020 $10.00M +233.6% 2018 $3.00M +258.2% 2017 $837.0K — Quarterly Revenue … Read more
Quick Answer ABEONA THERAPEUTICS INC. reported Total Revenue of $5.82 million for fiscal year 2025. ABEONA THERAPEUTICS INC. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $5.82M +66.3% 2023 $3.50M +147.5% 2022 $1.41M -52.9% 2021 $3.00M -70.0% 2020 $10.00M +233.6% 2018 $3.00M +258.2% 2017 $837.0K -5.8% 2016 $889.0K -14.5% 2015 $1.04M … Read more